|
Market Closed -
Nasdaq
23:00:00 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 23.04 USD | -2.29% |
|
-4.79% | +30.61% |
| 10-27 | Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading | MT |
| 10-26 | Zai Lab's Lung Cancer Drug Achieves Promising Response Rate in Phase 1b Trial; Shares up 4% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZAI LAB LIMITED | Biopharmaceuticals | -2.29% | -4.79% | +30.61% | -9.33% | -78.10% | 2.65B |  |  | |
- Stock Market
- Stocks
- ZLAB Stock
- Charts Zai Lab Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
